Radiotherapy Twice A Day Halves Treatment Time
|
By MedImaging International staff writers Posted on 16 Jun 2016 |
|
Radiotherapy (RT) once a day for six and a half weeks or twice a day for three weeks offer equal benefit in non-metastatic small cell lung cancer (SCLC), according to a new study.
Researchers at the University of Manchester (United Kingdom), the Catalan Institute of Oncology (ICO; Barcelona, Spain), and other institutions conducted a study that recruited 550 patients diagnosed with SCLC from 74 centers in eight countries between 2008 and 2013. The patients were randomized to receive either concurrent twice-daily RT over three weeks or concurrent once-daily RT over 6.5 weeks, both starting on day 22 of cycle 1. Patients were followed up until death. The primary end point was overall survival.
The results showed that survival in both groups was similar, with 56% of patients who had RT twice a day surviving for two years, compared with 51% of those given it once a day. The majority of side effects from RT were similar in both groups, apart from neutropenia, which happened more often in twice daily treatment group. The trial also identified the optimum amount of RT as 66 grays once a day and 45 grays twice a day. The study was presented at the American Society of Clinical Oncology (ASCO) cancer conference, held during June 2016 in Chicago (IL, USA).
“Before this study, it was unclear whether having radiotherapy once or twice a day helped more patients survive for longer, and what level of side effects was expected with modern radiotherapy techniques,” said lead author Professor Corinne Faivre-Finn, MD, PhD, of the University of Manchester. “We're pleased to provide answers to these questions, and our results have already begun to change practice around the world. Small cell lung cancer patients will be able to choose between a shorter course of radiotherapy given twice a day and a longer course given once a day.”
Primary lung cancers are malignant carcinomas that derive from epithelial cells, with the main types being SCLC and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
Related Links:
University of Manchester
Catalan Institute of Oncology
Researchers at the University of Manchester (United Kingdom), the Catalan Institute of Oncology (ICO; Barcelona, Spain), and other institutions conducted a study that recruited 550 patients diagnosed with SCLC from 74 centers in eight countries between 2008 and 2013. The patients were randomized to receive either concurrent twice-daily RT over three weeks or concurrent once-daily RT over 6.5 weeks, both starting on day 22 of cycle 1. Patients were followed up until death. The primary end point was overall survival.
The results showed that survival in both groups was similar, with 56% of patients who had RT twice a day surviving for two years, compared with 51% of those given it once a day. The majority of side effects from RT were similar in both groups, apart from neutropenia, which happened more often in twice daily treatment group. The trial also identified the optimum amount of RT as 66 grays once a day and 45 grays twice a day. The study was presented at the American Society of Clinical Oncology (ASCO) cancer conference, held during June 2016 in Chicago (IL, USA).
“Before this study, it was unclear whether having radiotherapy once or twice a day helped more patients survive for longer, and what level of side effects was expected with modern radiotherapy techniques,” said lead author Professor Corinne Faivre-Finn, MD, PhD, of the University of Manchester. “We're pleased to provide answers to these questions, and our results have already begun to change practice around the world. Small cell lung cancer patients will be able to choose between a shorter course of radiotherapy given twice a day and a longer course given once a day.”
Primary lung cancers are malignant carcinomas that derive from epithelial cells, with the main types being SCLC and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
Related Links:
University of Manchester
Catalan Institute of Oncology
Digital Radiographic System
OMNERA 300M
New
Ultrasound Needle Guide
Ultra-Pro 3
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Silver Member
X-Ray QA Meter
T3 AD Pro
Latest Radiography News
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
- AI-Powered Chest X-Ray Detects Pulmonary Nodules Three Years Before Lung Cancer Symptoms
- AI Model Identifies Vertebral Compression Fractures in Chest Radiographs
- Advanced 3D Mammography Detects More Breast Cancers
Channels
MRI
view channel
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read more
First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
Each year, approximately 800,000 people in the U.S. experience strokes, with marginalized and minoritized groups being disproportionately affected. Strokes vary in terms of size and location within the... Read moreUltrasound
view channel
Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a highly promising cancer treatment, especially for bloodborne cancers like leukemia. This highly personalized therapy involves extracting... Read more
Tiny Magnetic Robot Takes 3D Scans from Deep Within Body
Colorectal cancer ranks as one of the leading causes of cancer-related mortality worldwide. However, when detected early, it is highly treatable. Now, a new minimally invasive technique could significantly... Read more
High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis
Each year, approximately one million prostate cancer biopsies are conducted across Europe, with similar numbers in the USA and around 100,000 in Canada. Most of these biopsies are performed using MRI images... Read more
World's First Wireless, Handheld, Whole-Body Ultrasound with Single PZT Transducer Makes Imaging More Accessible
Ultrasound devices play a vital role in the medical field, routinely used to examine the body's internal tissues and structures. While advancements have steadily improved ultrasound image quality and processing... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read more
General/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more